These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7999969)

  • 41. Adult weight change and risk of postmenopausal breast cancer.
    Eliassen AH; Colditz GA; Rosner B; Willett WC; Hankinson SE
    JAMA; 2006 Jul; 296(2):193-201. PubMed ID: 16835425
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hormone concentrations in the homogenates of ovarian tissue and blood serum in postmenopausal women not using hormone therapy.
    Brodowski J; Brodowska A; Laszczyńska M; Chlubek D; Starczewski A
    Gynecol Endocrinol; 2012 May; 28(5):396-9. PubMed ID: 22420607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cancer risk under hormone therapy].
    Lauritzen C
    Ther Umsch; 1994 Nov; 51(11):755-66. PubMed ID: 7839334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Leukemia and other cancers following radiation treatment of pelvic disease.
    Smith PG
    Cancer; 1977 Apr; 39(4 Suppl):1901-5. PubMed ID: 404023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lung cancer risk and radiation dose among women treated for breast cancer.
    Inskip PD; Stovall M; Flannery JT
    J Natl Cancer Inst; 1994 Jul; 86(13):983-8. PubMed ID: 8007020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause.
    Hughes CL; Wall LL; Creasman WT
    Gynecol Oncol; 1991 Jan; 40(1):42-5. PubMed ID: 1824939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Can breast cancer be prevented?].
    Vatten LJ
    Tidsskr Nor Laegeforen; 1991 May; 111(14):1745-8. PubMed ID: 2063386
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Female sex hormones increase the risk of breast cancer].
    Vatten L
    Tidsskr Nor Laegeforen; 1998 Aug; 118(19):2969-74. PubMed ID: 9748837
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients.
    Mullooly M; Yang HP; Falk RT; Nyante SJ; Cora R; Pfeiffer RM; Radisky DC; Visscher DW; Hartmann LC; Carter JM; Degnim AC; Stanczyk FZ; Figueroa JD; Garcia-Closas M; Lissowska J; Troester MA; Hewitt SM; Brinton LA; Sherman ME; Gierach GL
    Breast Cancer Res; 2017 Jan; 19(1):8. PubMed ID: 28103902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Normal tissue tolerance to external beam radiation therapy: ovaries].
    Gross E; Champetier C; Pointreau Y; Zaccariotto A; Dubergé T; Guerder C; Ortholan C; Chauvet B
    Cancer Radiother; 2010 Jul; 14(4-5):373-5. PubMed ID: 20430663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk.
    Spicer DV; Ursin G; Parisky YR; Pearce JG; Shoupe D; Pike A; Pike MC
    J Natl Cancer Inst; 1994 Mar; 86(6):431-6. PubMed ID: 8120917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Links between hormone replacement therapy and neoplasia.
    Hulka BS
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):168S-175S. PubMed ID: 7958013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiology of endometrial cancer.
    Voigt LF; Weiss NS
    Cancer Treat Res; 1989; 49():1-21. PubMed ID: 2577197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ovarian ablation for premenopausal breast cancer: A review of treatment considerations and the impact of premature menopause.
    Nourmoussavi M; Pansegrau G; Popesku J; Hammond GL; Kwon JS; Carey MS
    Cancer Treat Rev; 2017 Apr; 55():26-35. PubMed ID: 28288389
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A prospective cohort study of postmenopausal hormone use and risk of breast cancer in US women.
    Buring JE; Hennekens CH; Lipnick RJ; Willett W; Stampfer MJ; Rosner B; Peto R; Speizer FE
    Am J Epidemiol; 1987 Jun; 125(6):939-47. PubMed ID: 3578252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics.
    Dai Q; Franke AA; Yu H; Shu XO; Jin F; Hebert JR; Custer LJ; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):497-502. PubMed ID: 12814993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Radiotherapy of benign gynecological diseases].
    Fontana C; Bergonzini R
    Radiobiol Radioter Fis Med; 1969; 24(6):369-85. PubMed ID: 5404331
    [No Abstract]   [Full Text] [Related]  

  • 60. Concentration of cytosolic estrogen receptors in patients with postmenopausal osteoporosis.
    Davidson BJ; Riggs BL; Coulam CB; Toft DO
    Am J Obstet Gynecol; 1980 Feb; 136(4):430-3. PubMed ID: 7355923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.